Dulaglutide
Definition
A once-weekly GLP-1 receptor agonist marketed as Trulicity for type 2 diabetes (0.75 / 1.5 / 3.0 / 4.5 mg). The REWIND trial established cardiovascular benefit in a majority primary-prevention population. NOT FDA-approved for chronic weight management; off-label weight-loss effect is modest (~3-6% TBWL).
Definition curated by Weight Loss Rankings — sourced from FDA labels and peer-reviewed PubMed literature, never AI-generated summaries.
Related terms in drug
Looking for more depth?
- Trulicity drug page
- Browse the full GLP-1 glossary (124 terms across 8 categories)
- Research articles — primary-source deep dives
- Tools and calculators
- Compare GLP-1 telehealth providers